| Metric | Value (₹ Cr) | vs Q2 FY25 |
|---|---|---|
| Revenue | 704.45 | 4.0% |
| Total Income | 718.30 | 3.8% |
| Expenditure | 604.46 | 1.0% |
| PBT | 113.84 | 16.1% |
| Net Profit | 87.40 | 16.8% |
| OPM | 11.96% | 2.74pp |
| NPM | 12.17% | 1.90pp |
| EPS | 2.38 | 16.8% |
Jyothy Labs Reports 4% Value Growth and 8% Volume Growth in Q3FY25
31 Jan 2025 · 31 Jan 2025, 07:16 pm
Summary
Jyothy Labs Limited, a prominent Indian FMCG company, announced its financial results for the quarter ending December 31, 2024. The company reported a 4% increase in value and 8% in volume over the same period last year, with a consolidated revenue of Rs. 704 crores. The EBITDA margin for the quarter is 16.4%. For the nine-month period ended, revenue reached Rs. 2,180 crores, representing 4% and 7.2% value growth and volume growth respectively.
Key Highlights
- 1
Healthy 8% volume growth in Q3 despite headwinds
- 2
EBITDA margin at 16.4% (Rs 115.8 crore) versus 17.5% (Rs 118.6 crores)
- 3
Net Sales at Rs. 2180 crores, up by 4% for YTD FY2025
- 4
Segment performance: Fabric Care - 9.3% revenue growth, Dishwashing - 3.6% revenue growth, Personal Care - 3.7% revenue decline, Household Insecticides - 24.8% revenue decline
- 5
Launched JOVIA beauty soap and Maxo Anti-Mosquito Racquet
Management Comments
Ms. M R Jyothy
4% value growth and 8% volume growth in the quarter is a testimony of our resilience amid not so favorable demand environment. At the nine-month mark in the current financial year, 7.2% volume growth indicates that our strategic approach and initiatives can keep up the growth momentum even when the external environment is not so conducive.
Informational and educational content only. Not investment advice.